ArticleJournal of pharmacy & bioallied sciences2025
Analysis of Plant-Based and Herbal Therapies in Periodontal Treatment: Clinical Applications, Mechanistic Insights, and Efficacy.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Periodontitis, a widespread chronic inflammatory disease, is primarily treated with scaling and root planing (SRP). However, plant-based adjunctive therapies, known for their anti-inflammatory, antimicrobial, and antioxidant effects, are emerging as valuable complements to SRP. This review presents findings from 24 studies on agents such as Edelweiss stem cells, pomegranate, neem, chamomile, and curcumin, which showed enhanced clinical outcomes in probing pocket depth (PPD) and clinical attachment levels (CAL) when used with SRP. These therapies offer safe and biocompatible alternatives to synthetic agents, potentially reducing antibiotic dependence and addressing antimicrobial resistance. The localized application of these agents maximizes periodontal benefits with minimal systemic exposure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.